# Evaluation of the Translation of the DE-PLAN Program for the Primary Prevention of Type 2 Diabetes in Routine Primary Care

Study · id `cardio:ct-nct01365013` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01365013](<https://clinicaltrials.gov/study/NCT01365013>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01365013

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1113 participants.

## Technical summary

Registry record NCT01365013. Randomized; single masking; primary purpose prevention. Start 2011-06 (registry gives no type); primary completion 2013-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1113 participants (enrolled count; ClinicalTrials.gov record NCT01365013, source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01365013, source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)
- Primary completion: 2013-06 (actual) (ClinicalTrials.gov record NCT01365013, source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01365013, source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)
- Countries: Spain (ClinicalTrials.gov record NCT01365013, source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01365013-2016-07-29`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of the Translation of the DE-PLAN Program for the Primary Prevention of Type 2 Diabetes in Routine Primary Care
- Acronym: DE-PLAN E
- Condition: Prediabetic State
- Intervention (Behavioral): DE-PLAN
- Intervention (Behavioral): Control group
- Lead sponsor: Basque Health Service
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: Basque Health Service (`cardio:org-basque-health-service`)

## Provenance

Content hash: 7099795801bb1da3e49dfeaeedaa90b24bbce0f3c404f5db8bf2b492b3b4c04b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
